Home / Uncategorized / GenSight Biologics Announces Publication of Positive Safety Data from Phase I/II Trial of GS010 in the JAMA Ophthalmology

GenSight Biologics Announces Publication of Positive Safety Data from Phase I/II Trial of GS010 in the JAMA Ophthalmology

Business Wire – PARIS — –Feb 12, 2019–Regulatory News:
Source: New feed

About bingpedia

Check Also

Rents are up? That depends where you live

MSN – <p>The cost of renting a one-bedroom in New York City actually went down …

Leave a Reply

Your email address will not be published. Required fields are marked *